KKR has completed its purchase of WebMD.
As of the expiration of the tender offer, almost 30.6 million shares of common stock of WebMD representing 78.7% of the issued and outstanding shares of WebMD (including restricted shares), were tendered into and not withdrawn from the tender offer.
What does this mean for marketers? Probably not much in the short term as WebMD is unlikely to change its ad policies any time soon but it will be interesting to see if it remains a standalone property or if it starts using networks like DoubleClick.
Source: Drug Store News